Shashaj B, Busetto E, Sulli N
Department of Pediatrics, Diabetes Center, La Sapienza University of Rome, Rome, Italy.
Diabet Med. 2008 Sep;25(9):1036-42. doi: 10.1111/j.1464-5491.2008.02549.x.
To assess the efficacy in pre- and postprandial glycaemic control and the impact on treatment satisfaction of a bolus calculator (Bolus Wizard) incorporated into the insulin pump in Type 1 diabetic (T1D) paediatric patients using continuous subcutaneous insulin infusion (CSII) treatment at various stages of pubertal development.
Thirty-six T1D patients on CSII treatment (19 males; mean age 13.9 +/- 3.5 years; range 4.9-17.8 years), were prospectively enrolled into this two-period crossover study. Eighteen patients were randomized to begin phase A using the Bolus Wizard, followed by phase B, using their current conventional insulin dosing method to determine pre-meal boluses. The remaining subjects were randomized to begin with phase B followed by phase A. Each study period lasted 2 weeks. A questionnaire assessing treatment satisfaction with the Bolus Wizard was compiled.
There was a significant reduction in blood glucose levels before and 2 h after meals and in the number of correction boluses during phase A with respect to phase B of the study. The lower frequency of hypoglycaemic events during phase A did not reach statistical significance. There were no differences between the two phases: insulin requirement, daily bolus rate (%) and meal bolus quantity.
When paediatric patients used CSII, the bolus insulin dose calculated using the Bolus Wizard was more effective in improving pre- and postprandial glycaemic control with fewer correction boluses, without differences in the prandial insulin requirements and without restriction in the carbohydrate content of meals. The use of the Bolus Wizard was easy and was associated with a high level of satisfaction in these patients.
评估在1型糖尿病(T1D)儿科患者中,在青春期发育的各个阶段使用持续皮下胰岛素输注(CSII)治疗时,胰岛素泵中内置的大剂量计算器(Bolus Wizard)对餐前和餐后血糖控制的疗效以及对治疗满意度的影响。
36例接受CSII治疗的T1D患者(19例男性;平均年龄13.9±3.5岁;范围4.9 - 17.8岁),被前瞻性纳入这项两阶段交叉研究。18例患者随机开始A阶段,使用Bolus Wizard,随后进入B阶段,使用他们当前的常规胰岛素给药方法确定餐前大剂量。其余受试者随机先开始B阶段,随后进入A阶段。每个研究阶段持续2周。编制了一份评估对Bolus Wizard治疗满意度的问卷。
与研究的B阶段相比,A阶段进餐前和进餐后2小时的血糖水平以及校正大剂量的数量均显著降低。A阶段低血糖事件的较低发生率未达到统计学显著性。两个阶段之间在胰岛素需求量、每日大剂量率(%)和进餐大剂量数量方面没有差异。
儿科患者使用CSII时,使用Bolus Wizard计算的大剂量胰岛素在改善餐前和餐后血糖控制方面更有效,校正大剂量更少,在进餐胰岛素需求量方面没有差异,并且对餐食的碳水化合物含量没有限制。Bolus Wizard的使用简便,且这些患者对其满意度较高。